journal article·2020-02-25

Nanoscale Analysis of Randall’s Plaques by Electron Energy Loss Spectromicroscopy: Insight in Early Biomineral Formation in Human Kidney

Clément Gay, Emmanuel Letavernier, Marie-Christine Verpont, Michael Walls, Dominique Bazin, Michel Daudon, Nadine Nassif, Odile Stéphan, Marta de Frutos

ACS Nano· Volume 14· Issue 2
Publisher page

Abstract

Idiopathic kidney stones originate mainly from calcium phosphate deposits at the tip of renal papillae, known as Randall's plaques (RPs), also detected in most human kidneys without stones. However, little is known about the mechanisms involved in RP formation. The localization and characterization of such nanosized objects in the kidney remain a real challenge, making their study arduous. This study provides a nanoscale analysis of the chemical composition and morphology of incipient RPs, characterizing in particular the interface between the mineral and the surrounding organic compounds. Relying on data gathered from a calculi collection, the morphology and chemical composition of incipient calcifications in renal tissue were determined using spatially resolved electron energy-loss spectroscopy. We detected microcalcifications and individual nanocalcifications found at some distance from the larger ones. Strikingly, concerning the smaller ones, we show that two types of nanocalcifications coexist: calcified organic vesicles and nanometric mineral granules mainly composed of calcium phosphate with carbonate in their core. Interestingly, some of these nanocalcifications present similarities with those reported in physiological bone or pathological cardiovascular biominerals, suggesting possible common formation mechanisms. However, the high diversity of these nanocalcifications suggests that several mechanisms may be involved (nucleation on a carbonate core or on organic compounds). In addition, incipient RPs also appear to present specific features at larger scales, revealing secondary calcified structures embedded in a fibrillar organic material. Our study proves that analogies exist between physiological and pathological biominerals and provides information to understand the physicochemical processes involved in pathological calcification formation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Kidney Stones and Urolithiasis Treatments · Pediatric Urology and Nephrology Studies · Dialysis and Renal Disease Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratoire de Physique des Solides, CNRS UMR 8502, Université de Paris-Saclay, F-91405, Orsay, France

Sorbonne Université, UPMC Univ Paris 06, UMR S 1155, F-75020, Paris, France

INSERM, UMR S 1155, F-75020, Paris, France

Physiology Unit, APHP, Hôpital Tenon, F-75020, Paris, France

Laboratoire de Chimie Physique, UMR 8000-CNRS, Université de Paris-Saclay, F-91405, Orsay, France

Sorbonne Université, CNRS, Collège de France, Laboratoire de Chimie de la Matière Condensée de Paris (LCMCP), 4 Place Jussieu, F-75005, Paris, France

Funding

FP7 Research infrastructures · Centre National de la Recherche Scientifique

References (68)

Show source-provided references
1. Bonucci E. · 2007
2. 10.1021/cr200068d10.1021/cr200068d ↗
3. 10.1038/nmat362710.1038/nmat3627 ↗
4. 10.1056/NEJMc080099010.1056/NEJMc0800990 ↗
5. 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-# ↗
6. Daudon M. · Scanning Microsc. · 1993 · 7 · 1081
7. Daudon M. · 2012 · 11310.1007/978-1-4471-4387-1_15 ↗
8. 10.1038/nrdp.2016.810.1038/nrdp.2016.8 ↗
9. 10.1016/j.crci.2014.12.00510.1016/j.crci.2014.12.005 ↗
10. 10.1007/s00240-014-0701-010.1007/s00240-014-0701-0 ↗
11. 10.1056/NEJM19360206214060310.1056/NEJM193602062140603 ↗
12. 10.1097/00000658-193706000-0001410.1097/00000658-193706000-00014 ↗
13. 10.1007/s00240-018-1079-110.1007/s00240-018-1079-1 ↗
14. 10.1016/j.juro.2016.04.08610.1016/j.juro.2016.04.086 ↗
15. 10.1063/1.272355610.1063/1.2723556 ↗
16. 10.1016/j.actbio.2015.03.03910.1016/j.actbio.2015.03.039 ↗
17. 10.1021/acsnano.6b0244310.1021/acsnano.6b02443 ↗
18. 10.1073/pnas.120891610910.1073/pnas.1208916109 ↗
19. 10.1021/acsnano.6b0529710.1021/acsnano.6b05297 ↗
20. 10.1016/j.micron.2013.02.01010.1016/j.micron.2013.02.010 ↗
21. 10.1073/pnas.080335410510.1073/pnas.0803354105 ↗
22. 10.1002/jcp.2596910.1002/jcp.25969 ↗
23. 10.1002/jemt.2303110.1002/jemt.23031 ↗
24. 10.1111/j.1523-1755.2005.00388.x10.1111/j.1523-1755.2005.00388.x ↗
25. 10.1016/j.juro.2011.10.12510.1016/j.juro.2011.10.125 ↗
26. 10.1016/j.actbio.2014.10.00310.1016/j.actbio.2014.10.003 ↗
27. 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-110.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
28. 10.1111/j.1472-4677.2004.00039.x10.1111/j.1472-4677.2004.00039.x ↗
29. 10.1107/S090904951002002910.1107/S0909049510020029 ↗
30. 10.1021/jacs.5b0793110.1021/jacs.5b07931 ↗
31. 10.1016/j.msec.2013.05.03810.1016/j.msec.2013.05.038 ↗
32. 10.1016/j.jeurceramsoc.2005.02.00710.1016/j.jeurceramsoc.2005.02.007 ↗
33. 10.1107/S090904950900021110.1107/S0909049509000211 ↗
34. 10.1016/j.bone.2015.08.01810.1016/j.bone.2015.08.018 ↗
35. 10.1103/PhysRevB.42.545910.1103/PhysRevB.42.5459 ↗
36. 10.1039/C4NR05922K10.1039/C4NR05922K ↗
38. 10.1016/j.jsb.2009.02.00110.1016/j.jsb.2009.02.001 ↗
39. 10.1016/0889-1605(86)90037-610.1016/0889-1605(86)90037-6 ↗
40. 10.1016/j.jsb.2011.03.01410.1016/j.jsb.2011.03.014 ↗
41. 10.1016/j.bbagen.2009.09.00610.1016/j.bbagen.2009.09.006 ↗
42. 10.1016/j.jsb.2008.02.00110.1016/j.jsb.2008.02.001 ↗
43. 10.1681/ASN.201710114810.1681/ASN.2017101148 ↗
44. 10.1016/j.urology.2013.11.00410.1016/j.urology.2013.11.004 ↗
45. 10.1002/ar.2327510.1002/ar.23275 ↗
46. 10.1016/j.bone.2006.02.05910.1016/j.bone.2006.02.059 ↗
47. 10.1021/cg901199h10.1021/cg901199h ↗
48. 10.1039/C3MH00071K10.1039/C3MH00071K ↗
49. 10.1016/j.biomaterials.2013.07.09610.1016/j.biomaterials.2013.07.096 ↗
50. 10.1152/ajprenal.00696.201210.1152/ajprenal.00696.2012 ↗
51. 10.1038/sj.ki.500202010.1038/sj.ki.5002020 ↗
52. Obrador G. · J. Am. Soc. Nephrol. · 1998 · 9 · 74610.1681/ASN.V95746 ↗
53. 10.1007/s00240-014-0703-y10.1007/s00240-014-0703-y ↗
54. 10.1038/nmat287510.1038/nmat2875 ↗
55. 10.1021/cm011063z10.1021/cm011063z ↗
56. 10.1007/s00240-014-0705-910.1007/s00240-014-0705-9 ↗
57. 10.1016/j.bone.2015.05.01310.1016/j.bone.2015.05.013 ↗
58. 10.1073/pnas.091421810710.1073/pnas.0914218107 ↗
59. 10.1681/ASN.200410089510.1681/ASN.2004100895 ↗
60. 10.1016/j.bone.2016.04.00710.1016/j.bone.2016.04.007 ↗
61. 10.1007/BF0256400410.1007/BF02564004 ↗
62. 10.1016/0169-6009(92)90881-D10.1016/0169-6009(92)90881-D ↗
63. 10.1016/S0074-7696(04)42003-810.1016/S0074-7696(04)42003-8 ↗
64. 10.1161/01.CIR.0000148367.08413.E910.1161/01.CIR.0000148367.08413.E9 ↗
65. 10.1172/JCI1703810.1172/JCI17038 ↗
66. 10.1016/0304-3991(92)90510-Q10.1016/0304-3991(92)90510-Q ↗
67. 10.1016/j.ultramic.2010.10.00110.1016/j.ultramic.2010.10.001 ↗
68. Francisco de la Peña; Prestat, E.; Fauske, T.; Burdet, P.; Jokubauskas, P.; Nord, M.; Ostasevicius, T.; MacArthur, K. E.; Sarahan, M.; Johnstone, D. N.; Taillon, J.; Lähnemann, J.; Migunov, V.; Eljarrat, A.; Caron, J.; Aarholt, T.; Mazzucco, S.; Walls, M.; Slater, T.; Winkler, F.Hyperspy/Hyperspy: HyperSpy v1.5.2; Zenodo, 2019.